Search

You searched for "associate"

540 results found

Testosterone and erectile function – the debate goes on!

1 May 2018 | | Andrology, Basic Science Research
The most common causes of erectile dysfunction (ED) as per European Association of Urology (EAU) guidelines are: psychogenic, vasculogenic, neurogenic and hormonal. The EAU 2017 guidelines recommend measuring total testosterone (TS) level. This study is a meta-analysis of 14 randomised...

Non-antibiotic options for recurrent UTI

1 May 2018 | | Basic Science Research, Functional Urology, Infection
Recurrent urinary tract infection (UTI) imposes a heavy burden on health services. By definition recurrent UTI is two infections in six months or three in one year. The annual incidence of single UTI is 30 per 1000 women. The Scottish...

BPH therapy: how to find one’s way through the maze?

1 September 2015 | | Functional Urology
This communication is from the Young Academic Urologists (YAU) group of the European Association of Urologists (EAU). A purpose-built questionnaire of current practice was sent to 2000 members, of which 637 responded (68% were aged 50 or younger). Alpha blockers...

Reflux oesophagitis and risk of interstitial cystitis: is there a link?

1 March 2014 | | Functional Urology
This study aims to explore the potential link between reflux oesophagitis (RE) and interstitial cystitis / bladder pain syndrome (IC/BPS). IC/BPS is a chronic disease which is difficult to diagnose and treat. Two percent of the population may be affected....

Incidence and risk factors of suicide after a prostate cancer diagnosis

1 September 2019 | | Urologic Oncology
This is an observational study looking at 1,281,393 men diagnosed with prostate cancer and 842,294 matched prostate cancer-free men. There was an overall increased relative risk of suicide of 2.01 in men diagnosed with prostate cancer compared to those without,...
The Journal of Urology cover image.

Refining management of non-visible haematuria

2 March 2022 | | Functional Urology, Infection, Urologic Oncology | costs and cost analysis, hematuria, practice guidelines as topic, urinary bladder neoplasms
The optimal evaluation of non-visible haematuria (NVH) continues to be debated, with competing interests of avoidance underdiagnosis and the harms of over-testing. Current National Institute for Health & Care Excellent (NICE) guidance recommends referral for patients ≥60 years with NVH....

EMUC19 - 11th European Multidisciplinary Congress on Urological Cancers

14 November 2019 -17 November 2019
Don’t miss the great opportunity to present your innovative research or to attend the 11th European Multidisciplinary Congress on Urological Cancers (EMUC19) from 14-17 November 2019 in Vienna, Austria. Registration is now open. You can submit your onco-urology abstract before...

Neuromodulation for lower urinary tract dysfunction – an ICS update

1 July 2018 | | Functional Urology, Technological Developments
Non-invasive and invasive electro-stimulation techniques have been extensively studied in the treatment of lower urinary tract and bowel dysfunction, including overactive bladder syndrome (OAB), non-obstructive chronic urinary retention, faecal incontinence and chronic pelvic pain. Currently, the most common indication for...

The doctor as the patient: receiving bad news

13 March 2023 | Urologic Oncology
This article, written by a GP working in the NHS, gives a unique insight into the experience of being a urology patient and some thoughtful advice on ‘breaking bad news’. Day 1 Alarm bells ring. It’s spotting an email from...

In conversation with Jo Cresswell

17 May 2021 |
We were delighted to catch up with Jo Cresswell, Vice-President of BAUS, about her career highlights and views on urology in general. Can you tell us a little bit about what led you into the field of urology and what...

Recent advances in the management of castration resistant prostate cancer

1 November 2017 | | Urologic Oncology
Castrate resistant prostate cancer (CRPC) is defined by disease progression despite androgen-deprivation therapy lowering testosterone to castrate levels. It may present as a rise in serum levels of prostate specific antigen (PSA), progression of pre-existing disease, or the appearance of...

‘One team’: our experience teaching catheter care and difficult urethral catheterisation to NHS Nightingale Hospital London volunteer staff members

4 September 2020 | | COVID-19 - Urology News, Functional Urology, Technological Developments
The NHS Nightingale Hospital London was launched in response to the COVID-19 pandemic. In mid-March 2020, the predicted scale of the pandemic was uncertain and there was concern that COVID-19 might overwhelm existing intensive care unit (ICU) capacity within weeks....